v3.25.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalents $ 6,025 $ 7,550
Investments 883 665
Accounts receivable, net 31,709 24,227
Inventories 5,632 6,692
Other current assets 2,486 2,732
Assets of businesses held for sale 0 7,004
Total current assets 46,735 48,870
Long-term investments 18,483 15,128
Reinsurance recoverables 4,207 4,378
Property and equipment 3,650 3,654
Goodwill 44,924 44,370
Other intangible assets 28,975 29,417
Other assets 3,389 2,786
Separate account assets 7,556  
Separate account assets 7,533 7,278
TOTAL ASSETS 157,919 155,881
Liabilities    
Current insurance and contractholder liabilities 6,018 5,388
Pharmacy and other service costs payable 30,301 28,465
Accounts payable 9,346 9,294
Accrued expenses and other liabilities 7,695 9,387
Short-term debt 3,093 3,035
Liabilities of businesses held for sale 0 2,410
Total current liabilities 56,453 57,979
Non-current insurance and contractholder liabilities 10,079 10,254
Deferred tax liabilities, net 6,997 6,975
Other non-current liabilities 3,873 3,215
Long-term debt 30,947 28,937
Separate account liabilities 7,556 7,278
TOTAL LIABILITIES 115,905 114,638
Contingencies — Note 16
Shareholders' equity    
Common stock [1] 4 4
Additional paid-in capital 31,698 31,288
Accumulated other comprehensive loss (2,799) (2,341)
Retained earnings 47,028 43,519
Less: Treasury stock, at cost (34,126) (31,437)
TOTAL SHAREHOLDERS' EQUITY 41,805 41,033
Noncontrolling interests 209 210
Total equity 42,014 41,243
Total liabilities and equity $ 157,919 $ 155,881
[1] Par value per share, $0.01; shares issued, 404 million as of September 30, 2025 and 403 million as of December 31, 2024; authorized shares, 600 million.